Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Harvard Bioscience Inc gives FY 2014 outlook

Thursday, 27 Feb 2014 07:01am EST 

Harvard Bioscience Inc:Expects FY 2014 revenues to be about the same as FY 2013 revenues.Expects FY 2014 non-GAAP EPS of $0.26 per diluted share.Expects FY 2014 GAAP EPS of $0.15 per diluted share.The company reported revenue of $105.2 mln in FY 2013. 

Company Quote

0.14 +2.82%
19 Dec 2014